Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.

Abeler-Dörner L, Rieger CC, Berger B, Weyd H, Gräf D, Pfrang S, Tarner IH, Schwarting A, Lorenz HM, Müller-Ladner U, Krammer PH, Kuhn A.

J Rheumatol. 2013 Oct;40(10):1683-96. doi: 10.3899/jrheum.121299. Epub 2013 Sep 15.

PMID:
24037549
4.

The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.

Båve U, Alm GV, Rönnblom L.

J Immunol. 2000 Sep 15;165(6):3519-26.

5.

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.

Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, Hilbrands LB, van der Vlag J.

Arthritis Rheumatol. 2016 Feb;68(2):462-72. doi: 10.1002/art.39417.

6.

Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.

Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH.

Arthritis Rheum. 2009 Aug;60(8):2304-13. doi: 10.1002/art.24719.

7.
8.

Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus.

Jin O, Kavikondala S, Mok MY, Sun L, Gu J, Fu R, Chan A, Yeung J, Nie Y, Lau CS.

Arthritis Res Ther. 2010;12(4):R137. doi: 10.1186/ar3075. Epub 2010 Jul 9.

9.

Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus.

Figueroa-Vega N, Galindo-Rodríguez G, Bajaña S, Portales-Pérez D, Abud-Mendoza C, Sánchez-Torres C, González-Amaro R.

Scand J Immunol. 2006 Dec;64(6):668-76.

10.

High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.

Hasan SI, Mohd Ashari NS, Mohd Daud K, Che Husin CM.

Int J Rheum Dis. 2013 Aug;16(4):430-6. doi: 10.1111/1756-185X.12062. Epub 2013 Apr 27.

PMID:
23992264
11.
12.

Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity.

Li Y, Zhao LD, Tong LS, Qian SN, Ren Y, Zhang L, Ding X, Chen Y, Wang YX, Zhang W, Zeng XF, Zhang FC, Tang FL, Zhang X, Ba DN, He W, Cao XT, Lipsky PE.

Arthritis Res Ther. 2012 May 23;14(3):R123. doi: 10.1186/ar3853.

13.

Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.

Robak E, Smolewski P, Wozniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.

Eur Cytokine Netw. 2004 Jul-Sep;15(3):222-30.

14.
15.

Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.

Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Rheum. 2007 Oct;56(10):3399-411.

16.

The interplay of dendritic cell subsets in systemic lupus erythematosus.

Palucka AK, Banchereau J, Blanco P, Pascual V.

Immunol Cell Biol. 2002 Oct;80(5):484-8. Review.

17.
18.

Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.

Cederblad B, Blomberg S, Vallin H, Perers A, Alm GV, Rönnblom L.

J Autoimmun. 1998 Oct;11(5):465-70.

PMID:
9802930
19.

Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.

Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D.

Eur J Immunol. 2008 Oct;38(10):2896-904. doi: 10.1002/eji.200838342.

20.

Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.

Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS.

Arthritis Rheum. 2001 Apr;44(4):856-65.

Supplemental Content

Support Center